Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58



Bonaca, Marc P, Wiviott, Stephen D, Zelniker, Thomas A, Mosenzon, Ofri, Bhatt, Deepak L, Leiter, Lawrence A, McGuire, Darren K, Goodrich, Erica L, De Mendonca Furtado, Remo Holanda, Wilding, John PH ORCID: 0000-0003-2839-8404
et al (show 8 more authors) (2020) Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58. Circulation, 142 (8). 734 - 747.

[img] Text
DECLARE-TIMI 58 Cardiac and Limb Outcomes in Patients with and without PAD 2020 03 27 Clean.docx - Accepted Version

Download (766kB)
Item Type: Article
Uncontrolled Keywords: amputation, dapagliflozin, heart failure, kidney complications, peripheral artery disease, SGLT2i, type 2 diabetes mellitus
Depositing User: Symplectic Admin
Date Deposited: 07 Oct 2020 09:16
Last Modified: 27 Jan 2022 16:10
DOI: 10.1161/CIRCULATIONAHA.119.044775
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3103678